[H] [C@] 1(O[C@@] (C[C@H] (O) [C@H] 1NC(C) =O) (O[C@H] 1[C@@H] (O) [C@@H] (CO) O[C@@H] (O[C@H] 2[C@H] (O) [C@@H] (O) [C@H] (OC[C@H] (NC([*] ) =O) [C@H] (O) \C=C\CCCCCCCCCCCCC) O[C@@H] 2CO) [C@@H] 1O) C(O) =O) [C@H] (O) [C@H] (O) CO |
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
antigen
Any substance that stimulates an immune response in the body, such as through antibody production or by presentation to a T-cell receptor after binding to a major histocompability complex (MHC).
|
|
View more via ChEBI Ontology
Outgoing
|
α- N- acetylneuraminyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1')- ceramide
(CHEBI:15681)
has part
α-Neu5Ac-(2→3)-β-D-Gal-(1→4)-β-D-Glc-yl group
(CHEBI:142767)
α- N- acetylneuraminyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1')- ceramide
(CHEBI:15681)
has role
antigen
(CHEBI:59132)
α- N- acetylneuraminyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1')- ceramide
(CHEBI:15681)
has role
mouse metabolite
(CHEBI:75771)
α- N- acetylneuraminyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1')- ceramide
(CHEBI:15681)
is a
α-N-acetylneuraminyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-ceramide
(CHEBI:79209)
α- N- acetylneuraminyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1')- ceramide
(CHEBI:15681)
is conjugate acid of
α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-N-acylsphingosine(1−)
(CHEBI:60065)
|
|
Incoming
|
α-Neu5Ac-(2→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer(34:1)
(CHEBI:134572)
is a
α- N- acetylneuraminyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1')- ceramide
(CHEBI:15681)
α-Neu5Ac-(2→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer(36:1)
(CHEBI:137836)
is a
α- N- acetylneuraminyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1')- ceramide
(CHEBI:15681)
α-Neu5Ac-(2→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer(38:2)
(CHEBI:134574)
is a
α- N- acetylneuraminyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1')- ceramide
(CHEBI:15681)
ganglioside GM3
(CHEBI:84118)
is a
α- N- acetylneuraminyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1')- ceramide
(CHEBI:15681)
α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-N-acylsphingosine(1−)
(CHEBI:60065)
is conjugate base of
α- N- acetylneuraminyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1')- ceramide
(CHEBI:15681)
|
(2S,3R,4E)- 2- (acylamino)- 3- hydroxyoctadec- 4- en- 1- yl 5- acetamido- 3,5- dideoxy- D- glycero- α- D- galacto- non- 2- ulopyranonosyl- (2→3)- β- D- galactopyranosyl- (1→4)- β- D- glucopyranoside
|
(Gal)1 (Glc)1 (Neu5Ac)1 (Cer)1
|
KEGG GLYCAN
|
(N-Acetylneuraminyl)-D-galactosyl-D-glucosylceramide
|
KEGG COMPOUND
|
(Neu5Ac)GM3
|
ChEBI
|
α- N- acetylneuraminosyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
|
ChEBI
|
α- N- acetylneuraminosyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucosylceramides
|
ChEBI
|
alpha-N-Acetylneuraminyl-2,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide
|
KEGG COMPOUND
|
α- Neu5Ac- (2→3)- β- D- Gal- (1→4)- β- D- Glc- (1↔1')- Cer
|
ChEBI
|
α- Neu5Ac- (2→3)- β- D- Galp- (1→4)- β- D- Glcp- (1↔1')- Cer
|
ChEBI
|
ganglioside GM3
|
ChEBI
|
GM3
|
KEGG COMPOUND
|
GM3 (NeuAc)
|
ChEBI
|
Hematoside
|
KEGG GLYCAN
|
monosialoganglioside GM3
|
ChEBI
|
N-Acetylneuraminyl-2,3-alpha-D-galactosyl-1,4-beta-D-glucosylceramide
|
KEGG COMPOUND
|
Neu5Ac-alpha2->3Gal-beta1->4Glc-beta1->1'Cer
|
KEGG COMPOUND
|
Neu5Acα2→3Galβ1→4Glcβ-Cer
|
ChEBI
|
NeuAc-GM3
|
ChEBI
|
NeuAcα2-3Galβ1-4Glcβ1-1'Cer
|
ChEBI
|
NeuAcα2→3Galβ1→4Glc-Cer
|
ChEBI
|
|